Kidney involvement in medium- and large-vessel vasculitis

被引:21
|
作者
Maritati, Federica [1 ]
Iannuzzella, Francesco [2 ]
Pavia, Maria P. [1 ]
Pasquali, Sonia [2 ]
Vaglio, Augusto [1 ]
机构
[1] Univ Hosp, Nephrol Unit, Parma, Italy
[2] Arcispedale S Maria Nuova, Nephrol Unit, Reggio Emilia, Italy
关键词
Polyarteritis nodosa; Giant-cell arteritis; Takayasu arteritis; Renal infarction; Renal artery stenosis; Periaortitis; Retroperitoneal fibrosis; IgG4; IDIOPATHIC RETROPERITONEAL FIBROSIS; GIANT-CELL ARTERITIS; RHEUMATOLOGY; 1990; CRITERIA; POOR-PROGNOSIS FACTORS; POLYARTERITIS-NODOSA; CHRONIC PERIAORTITIS; MICROSCOPIC POLYANGIITIS; POLYMYALGIA-RHEUMATICA; CLINICAL PRESENTATION; TAKAYASUS-ARTERITIS;
D O I
10.1007/s40620-016-0303-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Medium- and large-vessel vasculitides (MVV and LVV, respectively) comprise a heterogeneous group of disorders whose common denominator is the inflammatory involvement of vessels of medium and large size. This disease spectrum includes giant-cell arteritis and Takayasu's arteritis, which typically affect the aorta and its main branches, and Kawasaki's disease and polyarteritis nodosa, which involve medium-sized arteries. Chronic periaortitis, characterized by a perivascular fibro-inflammatory reaction affecting the abdominal aorta and the periaortic tissue, frequently has a systemic distribution, involving other segments of the aorta and its major branches, and could thus be included in this group. Unlike small-vessel vasculitides, MVV and LVV do not cause glomerulonephritis, although glomerular immune-mediated lesions and tubulo-interstitial nephritis occur with varying frequency. However, MVV and LVV can often involve the renal artery and its branches, causing a wide array of lesions that range from renal artery stenosis to intra-renal vasculitis causing renal ischaemia/infarction, microaneurysms and haemorrhage. This review focuses on renal involvement in MVV and LVV and underlines why renal abnormalities in these syndromes should not be overlooked.
引用
收藏
页码:495 / 505
页数:11
相关论文
共 50 条
  • [31] Nationwide clinical and epidemiological study of large-vessel vasculitis in Japan in 2017
    Konda, Naoko
    Sakai, Ryoko
    Saeki, Keigo
    Matsubara, Yuri
    Nakamura, Yosikazu
    Miyamae, Takako
    Nakaoka, Yoshikazu
    Harigai, Masayoshi
    MODERN RHEUMATOLOGY, 2023, 34 (01) : 167 - 174
  • [32] Large vessel vasculitis
    Caspary, L.
    Schellong, S.
    INTERNIST, 2009, 50 (08): : 958 - 963
  • [33] New Therapeutic Approaches to Large-Vessel Vasculitis
    Kaymakci, Mahmut S.
    Warrington, Kenneth J.
    Kermani, Tanaz A.
    ANNUAL REVIEW OF MEDICINE, 2024, 75 : 427 - 442
  • [34] New treatment strategies in large-vessel vasculitis
    Unizony, Sebastian
    Stone, John H.
    Stone, James R.
    CURRENT OPINION IN RHEUMATOLOGY, 2013, 25 (01) : 3 - 9
  • [35] Cyclophosphamide for large-vessel vasculitis: assessment of response by PET/CT
    Henes, J. C.
    Mueller, M.
    Pfannenberg, C.
    Kanz, L.
    Koetter, I.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) : S43 - S48
  • [36] Role of Imaging in the Diagnosis of Large and Medium-Sized Vessel Vasculitis
    Pipitone, Nicolo
    Versari, Annibale
    Hunder, Gene G.
    Salvarani, Carlo
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2013, 39 (03) : 593 - +
  • [37] Treatment of large-vessel vasculitis: where do we stand?
    Pipitone, N.
    Salvarani, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) : S3 - S5
  • [38] Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-vessel Vasculitis
    Banerjee, Shubhasree
    Quinn, Kaitlin A.
    Gribbons, K. Bates
    Rosenblum, Joel S.
    Civelek, Ali Cahid
    Novakovich, Elaine
    Merkel, Peter A.
    Ahlman, Mark A.
    Grayson, Peter C.
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (01) : 99 - 107
  • [39] Interleukin-6 and soluble interleukin-6 receptor are elevated in large-vessel vasculitis: a cross-sectional and longitudinal study
    Pulsatelli, L.
    Boiardi, L.
    Assirelli, E.
    Pazzola, G.
    Muratore, F.
    Addimanda, O.
    Dolzani, P.
    Versari, A.
    Casali, M.
    Magnani, L.
    Pignottil, E.
    Pipitone, N.
    Croci, S.
    Meliconi, R.
    Salvarani, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (01) : S102 - S110
  • [40] The Role of 18F-FDG PET/CT in Large-Vessel Vasculitis: Appropriateness of Current Classification Criteria?
    Balink, H.
    Bennink, R. J.
    van Eck-Smit, B. L. F.
    Verberne, H. J.
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014